230637-04-4,MFCD16834300
Catalog No.:AA002M06

230637-04-4 | 2-Bromo-5-methylimidazo[2,1-b][1,3,4]thiadiazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$215.00   $150.00
- +
100mg
95%
3 weeks  
$293.00   $205.00
- +
250mg
95%
3 weeks  
$393.00   $275.00
- +
500mg
95%
3 weeks  
$688.00   $482.00
- +
1g
95%
3 weeks  
$897.00   $628.00
- +
2.5g
95%
3 weeks  
$1,706.00   $1,194.00
- +
5g
95%
3 weeks  
$2,493.00   $1,745.00
- +
10g
95%
3 weeks  
$3,672.00   $2,570.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA002M06
Chemical Name:
2-Bromo-5-methylimidazo[2,1-b][1,3,4]thiadiazole
CAS Number:
230637-04-4
Molecular Formula:
C5H4BrN3S
Molecular Weight:
218.0744
MDL Number:
MFCD16834300
SMILES:
Cc1cn2c(n1)sc(n2)Br
Properties
Computed Properties
 
Complexity:
145  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2012/20215,2012,A1Locationinpatent:Page/Pagecolumn70

[2]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn45

[3]Abas,SitiNurdiana;Aguiar,AnnaCarolineCampos;Ang,Xiaoman;Blaquiere,Nicole;Bodenreider,Christophe;Campbell,Simon;Campo,Brice;Chan,Katherine;Chan,WaiLing;Chen,Yen-Liang;Cooper,RolandA.;Crespo-Fernandez,Benigno;Diagana,ThierryT.;Ding,Mei;Fang,Eric;Gamo,FranciscoJavier;Guiguemde,Armand;Huang,Richard;Jain,JayPrakash;Kirrane,Tom;Lakshminarayana,SureshB.;Lanshoeft,Christian;Lim,Jessie;Liu,Yugang;Mata,Anne-Catherine;Pei,Luying;Qumber,Jafri;Rosenthal,PhilipJ.;Sarko,Christopher;Schulz,Hanna;Shu,Wei;Sim,Sandra;Simon,Oliver;Straimer,Judith;Taft,BenjaminR.;Thompson,Christopher;Tumwebaze,Patrick;Vankadara,Subramanyam;Waldron,Grace;Yokokawa,Fumiaki;Zou,Bin;Angulo-Barturen,Iñigo;Jiménez-Díaz,MaríaBelén;Wagner,Jürgen[JournalofMedicinalChemistry,2022,vol.65,#5,p.3798-3813]

[4]Kong,Yi;Li,Shanshan;Liu,Shangde;Xie,Roujie;Yuan,Duo;Zhu,Xiong[EuropeanJournalofMedicinalChemistry,2021,vol.225]

[1]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn45-46

[1]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn50

[1]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2011/121317,2011,A1Locationinpatent:Page/Pagecolumn75

[2]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2012/20215,2012,A1Locationinpatent:Page/Pagecolumn70

[3]Abas,SitiNurdiana;Aguiar,AnnaCarolineCampos;Ang,Xiaoman;Blaquiere,Nicole;Bodenreider,Christophe;Campbell,Simon;Campo,Brice;Chan,Katherine;Chan,WaiLing;Chen,Yen-Liang;Cooper,RolandA.;Crespo-Fernandez,Benigno;Diagana,ThierryT.;Ding,Mei;Fang,Eric;Gamo,FranciscoJavier;Guiguemde,Armand;Huang,Richard;Jain,JayPrakash;Kirrane,Tom;Lakshminarayana,SureshB.;Lanshoeft,Christian;Lim,Jessie;Liu,Yugang;Mata,Anne-Catherine;Pei,Luying;Qumber,Jafri;Rosenthal,PhilipJ.;Sarko,Christopher;Schulz,Hanna;Shu,Wei;Sim,Sandra;Simon,Oliver;Straimer,Judith;Taft,BenjaminR.;Thompson,Christopher;Tumwebaze,Patrick;Vankadara,Subramanyam;Waldron,Grace;Yokokawa,Fumiaki;Zou,Bin;Angulo-Barturen,Iñigo;Jiménez-Díaz,MaríaBelén;Wagner,Jürgen[JournalofMedicinalChemistry,2022,vol.65,#5,p.3798-3813]

230637-04-4    98-80-6   
6-methyl-2-phenylimidazo2,1-b1,3,4thiadiazole 

[1]Copin,Chloe;Henry,Nicolas;Buron,Frederic;Routier,Sylvain[EuropeanJournalofOrganicChemistry,2012,#16,p.3079-3083]

[2]Copin,Chloe;Henry,Nicolas;Buron,Frederic;Routier,Sylvain[EuropeanJournalofOrganicChemistry,2012,#34,p.6804-6806]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 230637-04-4
Historical Records
Tags:230637-04-4 Molecular Formula|230637-04-4 MDL|230637-04-4 SMILES|230637-04-4 2-Bromo-5-methylimidazo[2,1-b][1,3,4]thiadiazole
Catalog No.: AA002M06
230637-04-4,MFCD16834300
230637-04-4 | 2-Bromo-5-methylimidazo[2,1-b][1,3,4]thiadiazole
Pack Size: 50mg
Purity: 95%
3 weeks
$215.00 $150.00
Pack Size: 100mg
Purity: 95%
3 weeks
$293.00 $205.00
Pack Size: 250mg
Purity: 95%
3 weeks
$393.00 $275.00
Pack Size: 500mg
Purity: 95%
3 weeks
$688.00 $482.00
Pack Size: 1g
Purity: 95%
3 weeks
$897.00 $628.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$1,706.00 $1,194.00
Pack Size: 5g
Purity: 95%
3 weeks
$2,493.00 $1,745.00
Pack Size: 10g
Purity: 95%
3 weeks
$3,672.00 $2,570.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA002M06
Chemical Name: 2-Bromo-5-methylimidazo[2,1-b][1,3,4]thiadiazole
CAS Number: 230637-04-4
Molecular Formula: C5H4BrN3S
Molecular Weight: 218.0744
MDL Number: MFCD16834300
SMILES: Cc1cn2c(n1)sc(n2)Br
Properties
Complexity: 145  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 10  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.3  
Downstream Synthesis Route
78-95-5    37566-39-5    230637-04-4 

[1]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2012/20215,2012,A1Locationinpatent:Page/Pagecolumn70

[2]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn45

[3]Abas,SitiNurdiana;Aguiar,AnnaCarolineCampos;Ang,Xiaoman;Blaquiere,Nicole;Bodenreider,Christophe;Campbell,Simon;Campo,Brice;Chan,Katherine;Chan,WaiLing;Chen,Yen-Liang;Cooper,RolandA.;Crespo-Fernandez,Benigno;Diagana,ThierryT.;Ding,Mei;Fang,Eric;Gamo,FranciscoJavier;Guiguemde,Armand;Huang,Richard;Jain,JayPrakash;Kirrane,Tom;Lakshminarayana,SureshB.;Lanshoeft,Christian;Lim,Jessie;Liu,Yugang;Mata,Anne-Catherine;Pei,Luying;Qumber,Jafri;Rosenthal,PhilipJ.;Sarko,Christopher;Schulz,Hanna;Shu,Wei;Sim,Sandra;Simon,Oliver;Straimer,Judith;Taft,BenjaminR.;Thompson,Christopher;Tumwebaze,Patrick;Vankadara,Subramanyam;Waldron,Grace;Yokokawa,Fumiaki;Zou,Bin;Angulo-Barturen,Iñigo;Jiménez-Díaz,MaríaBelén;Wagner,Jürgen[JournalofMedicinalChemistry,2022,vol.65,#5,p.3798-3813]

[4]Kong,Yi;Li,Shanshan;Liu,Shangde;Xie,Roujie;Yuan,Duo;Zhu,Xiong[EuropeanJournalofMedicinalChemistry,2021,vol.225]

230637-04-4    122775-35-3    1246372-36-0 

[1]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn45-46

269410-22-2    230637-04-4    1246372-46-2 

[1]CurrentPatentAssignee:FUNDACIONCENTRONACIONALDEINVESTIGACIONESONCOLOGICASCARLOSIIIES-WO2010/112874,2010,A1Locationinpatent:Page/Pagecolumn50

230637-04-4    1337919-16-0 

[1]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2011/121317,2011,A1Locationinpatent:Page/Pagecolumn75

[2]CurrentPatentAssignee:SPANISHNATIONALCANCERRESEARCHCENTER-WO2012/20215,2012,A1Locationinpatent:Page/Pagecolumn70

[3]Abas,SitiNurdiana;Aguiar,AnnaCarolineCampos;Ang,Xiaoman;Blaquiere,Nicole;Bodenreider,Christophe;Campbell,Simon;Campo,Brice;Chan,Katherine;Chan,WaiLing;Chen,Yen-Liang;Cooper,RolandA.;Crespo-Fernandez,Benigno;Diagana,ThierryT.;Ding,Mei;Fang,Eric;Gamo,FranciscoJavier;Guiguemde,Armand;Huang,Richard;Jain,JayPrakash;Kirrane,Tom;Lakshminarayana,SureshB.;Lanshoeft,Christian;Lim,Jessie;Liu,Yugang;Mata,Anne-Catherine;Pei,Luying;Qumber,Jafri;Rosenthal,PhilipJ.;Sarko,Christopher;Schulz,Hanna;Shu,Wei;Sim,Sandra;Simon,Oliver;Straimer,Judith;Taft,BenjaminR.;Thompson,Christopher;Tumwebaze,Patrick;Vankadara,Subramanyam;Waldron,Grace;Yokokawa,Fumiaki;Zou,Bin;Angulo-Barturen,Iñigo;Jiménez-Díaz,MaríaBelén;Wagner,Jürgen[JournalofMedicinalChemistry,2022,vol.65,#5,p.3798-3813]

230637-04-4    98-80-6   
6-methyl-2-phenylimidazo2,1-b1,3,4thiadiazole 

[1]Copin,Chloe;Henry,Nicolas;Buron,Frederic;Routier,Sylvain[EuropeanJournalofOrganicChemistry,2012,#16,p.3079-3083]

[2]Copin,Chloe;Henry,Nicolas;Buron,Frederic;Routier,Sylvain[EuropeanJournalofOrganicChemistry,2012,#34,p.6804-6806]

Building Blocks More >
23147-58-2
23147-58-2
2,5-Dihydroxy-1,4-dioxane
AA002MAH | MFCD00012133
23249-97-0
23249-97-0
3-(1H-Benzimidazol-2-yl)propanoic acid
AA002MLH | MFCD00041215
233764-31-3
233764-31-3
trans-4-(Boc-amino)-1-methylcyclohexanol
AA002MXE | MFCD12756180
23450-18-2
23450-18-2
1-benzyl-2-bromobenzene
AA002N86 | MFCD00079713
23574-01-8
23574-01-8
Methyl 3-(benzylamino)propanoate
AA002NMK | MFCD01475856
2364-54-7
2364-54-7
2-Isopropyl-5-methyl-4-nitrosophenol
AA002NXB | MFCD00013894
24469-50-9
24469-50-9
(E)-tert-Butyl 2-benzylidenehydrazinecarboxylate
AA002O5N | MFCD00158497
245679-66-7
245679-66-7
Methyl 4-(cyclohexylcarbamoyl)benzoate
AA002OHW | MFCD07844233
24641-31-4
24641-31-4
2-(4-Bromophenyl)quinoline
AA002OTP | MFCD03617895
247225-29-2
247225-29-2
3-((4,6-Dimethylpyrimidin-2-yl)thio)propanoic acid
AA002P54 | MFCD00457968
Submit
© 2017 AA BLOCKS, INC. All rights reserved.